共查询到20条相似文献,搜索用时 31 毫秒
1.
Natural cycle IVF in unexplained, endometriosis-associated and tubal factor infertility. 总被引:5,自引:0,他引:5
A K Omland P Fedorcsák R Storeng P O Dale T Abyholm T Tanbo 《Human reproduction (Oxford, England)》2001,16(12):2587-2592
BACKGROUND: To elucidate possible differences between unexplained and minimal peritoneal endometriosis-associated infertility, we studied their outcome in natural cycle IVF (NIVF). METHODS: A prospective cohort study was carried out on unexplained (33 couples), minimal peritoneal endometriosis-associated (30 couples) and tubal factor (24 couples) infertility in 223 NIVF cycles, using human chorionic gonadotrophin (HCG) for ovulation induction. RESULTS: During the first NIVF attempt, follicular and luteal phase oestradiol, FSH, LH and progesterone concentrations, as well as endometrial thickness and follicular diameter were similar among the three groups. Periovulatory follicular growth monitored from day of HCG administration to oocyte aspiration was significantly lowered in unexplained infertility compared with minimal endometriosis-associated and tubal factor infertility. The fertilization rate, clinical pregnancy rate per initiated cycle, per successful oocyte retrieval and per embryo transfer, in minimal endometriosis (80.0, 10.4, 16.0 and 23.5% respectively) were similar to that in tubal factor infertility patients (68.6, 5.8, 11.4 and 16.0%) but significantly higher (P < 0.05) than that of the unexplained infertility group (62.2, 2.6, 5.4 and 8.7%). CONCLUSIONS: The significant reduction in follicular periovulatory growth, fertilization and pregnancy rates in unexplained infertility compared with minimal peritoneal endometriosis patients may be explained by sub-optimal follicular development with possibly reduced oocyte quality, intrinsic embryo quality factors or by impaired implantation. From a clinical point of view, NIVF is less suited to unexplained infertility treatment, but might represent an interesting treatment option for minimal peritoneal endometriosis-associated infertility. 相似文献
2.
Ranieri M.; Beckett V.A.; Marchant S.; Kinis A.; Serhal P. 《Human reproduction (Oxford, England)》1995,10(8):2023-2026
A prospective randomized study was designed to compare gameteintra-Fallopian transfer (GIFT) and in-vitro fertilization (IVF)and embryo transfer in the treatment of couples who have failedto conceive after at least three cycles of ovarian stimulationand intrauterine insemination (IUI). A total of 69 couples withprimary unexplained infertility of at least 2 years' durationplus at least three failed cycles of ovarian stimulation andIUI were randomly allocated to either GIFT or IVF/embryo transfer.The clinical pregnancy rate was 34% after GIFT treatment and50% after IVF/embryo transfer. This difference was not statisticallysignificant. The twin rate in the IVF/embryo transfer groupwas higher than in the GIFT group (53 versus 17%, P = 0.005).We conclude that patients with unexplained infertility and failedovarian stimulation and IUI can still achieve encouraging pregnancyrates with IVF/embryo transfer or GIFT. Since IVF/embryo transferis the least invasive of the two procedures and may yield diagnosticinformation, we would favour this therapy; however, the numberof embryos transferred should be reduced to two to reduce therisk of twin pregnancy. 相似文献
3.
Li T.C.; Serle E.; Warren M.A.; Cooke I.D. 《Human reproduction (Oxford, England)》1993,8(7):1021-1024
A retrospective study was designed to examine the relationshipbetween luteinizing hormone (LH) concentrations in the follicularphase and endometrial development in the luteal phase of naturaland artificial cycles. Two types of cycle were studied: naturalcycles (n = 51) in subjects with unexplained infertility weredivided into two subgroups, depending on whether LH measurementsin the late follicular phase were based on urine (n = 24) orplasma (n = 27) samples; and artificial cycles (n = 17), producedby the administration of a standard hormone replacement therapy,in two subgroups of women, those with premature ovarian failure(n = 10) in whom plasma LH concentrations were high, and thosewith unexplained infertility (n = 7) who had their hypothalamicpituitary ovarian axis down-regulated and in whom plasmaLH concentrations were low. The correlation between plasma orurine concentrations of LH in the follicular phase and the resultsof endometrial biopsy obtained in the luteal phase was calculated.In natural cycles, LH concentrations were similar in those withnormal or retarded endometrium, and there was no significantcorrelation between high LH concentration and retarded endometrialdevelopment. In artificial cycles, endometrial development wasnot different between those with low LH concentrations (down-regulatedby Zoladex) and those with high LH concentrations (prematureovarian failure). Endometrial development in the peri-implantationperiod does not appear to be influenced by LH concentrationin the follicular phase. The reported association between highLH concentration and poor reproductive performance cannot thereforebe explained by abnormal implantation consequent upon retardedendometrial development. 相似文献
4.
Sengoku K.; Tamate K.; Takaoka Y.; Morishita N.; Ishikawa M. 《Human reproduction (Oxford, England)》1994,9(6):1043-1047
The use of gonadotrophin-releasing hormone agonist (GnRHa) incombination with human menopausal gonadotrophin (HMG) for ovulationinduction has been advocated for the treatment, particularlyby in-vitro fertilization (IVF) of various types of infertility.The present study was designed to compare the clinical efficacyof HMG alone with a short protocol of GnRHa/HMG for treatmentof unexplained infertility. A total of 91 couples with unexplainedinfertility were randomly assigned to one of two treatments;either HMG with intra-uterine insemination (IUI) (45 patients,62 cycles) or GnRHa/HMG with IUI (46 patients, 69 cycles) treatments.Progesterone concentrations on the day of human chorionic gonadotrophin(HCG) administration were significantly higher in HMG (1.5 ±0.9 ng/ml) versus GnRHa/HMG (0.8 ± 0.6 ng/ml; P <0.05)cycles. Furthermore, GnRHa suppressed the occurrences ofpremature luteinization (GnRHa/HMG 5.8% and HMG 24.2% respectively).However, there were no significant differences in HMG dose requirements,plasma oestradiol concentrations or follicular development onthe day of HCG administration between the two groups. Nor wereany significant differences found in the pregnancy rates betweenthe two treatment protocols (GnRHa/HMG 13.0% and HMG 11.3% respectively).Our results suggest no beneficial effect of GnRHa/HMG comparedto HMG alone for the treatment of unexplained infertility, basedon pregnancy rates. 相似文献
5.
Nip M.M.C.; Taylor P.V.; Rutherford A.J.; Hancock K.W. 《Human reproduction (Oxford, England)》1995,10(10):2564-2569
Immune reactions have effects at various concentrations in thereproductive process and autoantibodies may have an impact onfertility and the outcome of assisted conception. We measuredthe prevalence of and relation between antibodies to smoothmuscle, nuclear, phospholipid and sperm antigens, and concentrationsof immunoglobulins G, M and A and complement components C3 andC4, in the sera and follicular fluids of women with unexplainedinfertility (n = 30), endometriosis (n = 20), tubal infertility(n = 50) and the sera of 20 normal non-pregnant women. We assessedfertilization and successful pregnancy rates in relation toantibody status of infertile women after in vitro fertilization.All antibodies had a higher prevalence in infertile women comparedwith controls and this was significant for smooth muscle antibodyin endometriosis (P < 0.05); anticardiolipin antibody intubal infertility P < 0.05); and antisperm antibody in alltypes of infertility (P < 0.001). There was no relation betweenpresence of specific antibodies in serum or between serum andfollicular fluids. Total biochemical pregnancy rate was higherwith endometriosis (P = 0.05) but clinical pregnancy and livebirth rates did not differ between groups or in relation toantibody status. Significant differences in immunoglobulin andcomplement components occurred in women with and without successfulbiochemical pregnancy. 相似文献
6.
Cahill D. J.; Wardle P.G.; Harlow C.R.; Hull M.G.R. 《Human reproduction (Oxford, England)》1996,11(3):647-650
Evidence of pituitary-ovarian dysfunction in unexplained andendometriosis-associated infertility has been reported previously.Hormone-suppressive therapy is often used in an attempt to improvefertility, although benefits have not been proven. Our studyexamines the effect of progestogen (medroxyprogesterone acetate)treatment on women with endometriosis-associated and unexplainedinfertility, compared with women with tubal damage as functionalcontrols. Pre-ovulatory follicular size and serum and follicularfluid hormone concentrations were measured, and oocyte collectionand in-vitro fertilization were attempted, in natural cyclestotally unperturbed by exogenous gonadotrophins, for two cyclesbefore and two cycles following treatment with medroxyprogesteroneacetate for 2 months. In the endometriosis and unexplained infertilitygroups, compared with the tubal group, the treatment led tosignificant reductions in the integrated luteinizing hormone(LH) values (483 versus 664, 559 versus 762 and 864 versus 820notional IU/I respectively). There were no changes in serumoestradiol or follicular fluid oestradiol, progesterone, folliclestimulating hormone or LH concentrations after treatment Theresults suggest that progestogen therapy has no beneficial effecton the pituitary-ovarian dysfunction which contributes to endometriosis-associatedand unexplained infertility. 相似文献
7.
Ovarian response to repeated controlled stimulation in in-vitro fertilization cycles in patients with ovarian endometriosis 总被引:6,自引:0,他引:6
Al-Azemi M Bernal AL Steele J Gramsbergen I Barlow D Kennedy S 《Human reproduction (Oxford, England)》2000,15(1):72-75
In-vitro fertilization (IVF) is an effective infertility treatment for women with endometriosis, but most women need to undergo several cycles of treatment to become pregnant. This case-control study was designed to assess how consistently women with ovarian endometriosis respond to ovarian stimulation in consecutive treatment cycles compared to women with tubal infertility. We compared outcome measures in 40 women with a history of surgically confirmed ovarian endometriosis and 80 women with tubal infertility, all of whom had at least three IVF treatment cycles. The groups were matched for age and early follicular follicle stimulating hormone (FSH) concentration at their first IVF cycle. Outcome measures included number of follicles, number of oocytes, peak oestradiol concentration and number of FSH ampoules required per follicle. Cumulative pregnancy and live birth rates were calculated in both groups. The ovarian endometriosis group had a significantly poorer ovarian response and required significantly more ampoules of FSH per cycle, a difference that became greater with each subsequent cycle. However, cumulative pregnancy (63.3 versus 62.6% by fifth cycle) and live birth (46.8 versus 50.9% by fifth cycle) rates were similar in both groups. In conclusion, despite decreased ovarian response to FSH, ovarian endometriosis does not decrease the chances of successful IVF treatment. 相似文献
8.
S L Mandelbaum M P Diamond A H DeCherney 《American journal of reproductive immunology (New York, N.Y. : 1989)》1989,19(1):3-5
Antibodies to sperm head (ASA-H) are believed to impair reproduction, probably because of a reduction in fertilization of human oocytes. However, the incidence of ASA-H in couples with different etiologies of infertility undergoing in vitro fertilization/embryo transfer (IVF/ET) is unestablished. To examine this question, the semen, serum, and follicular fluid of 11 couples with unexplained infertility and 25 couples with tubal infertility undergoing IVF/ET were tested with the immunobead binding assay to identify ASA-H of IgA, IgG, and IgM isotypes. Comparing couples with unexplained vs. tubal infertility, 46% vs. 4% had ASA-H of at least one isotype in female serum (P = .006), 36% vs. 4% had ASA-H in follicular fluid (P = .023), 27% vs. 0% had ASA-H in semen (P = .023), and 18% vs. 4% had ASA-H in male serum (P = .022), respectively. ASA-H were present in one or more fluids tested in 55% of patients with unexplained infertility, compared to 8% of patients with tubal infertility (P = .005). Of the six women with ASA-H in their serum, 83% (5/6) were undergoing IVF/ET for unexplained infertility compared to 17% (1/6: P = .08) undergoing IVF/ET for tubal infertility. In summary, clinically significant ASA-H are present in a substantial number of infertile women undergoing IVF/ET, particularly those whose infertility is unexplained. Based on these findings, we conclude that it is efficacious to screen all women with unexplained infertility undergoing IVF/ET for ASA-H. 相似文献
9.
A randomized study comparing IVF in the unstimulated cycle with IVF following clomiphene citrate 总被引:1,自引:0,他引:1
Ingerslev HJ Højgaard A Hindkjaer J Kesmodel U 《Human reproduction (Oxford, England)》2001,16(4):696-702
The efficiency of IVF in unstimulated cycles was compared with that following ovarian stimulation with clomiphene citrate in a simple protocol with ultrasound monitoring only. A total of 132 couples with no previous IVF attempts, selected by female age <35 years, indication for intracytoplasmic sperm injection or infertility caused by tubal factor or unexplained infertility were randomized to the two protocols. Randomization yielded two comparable groups. The clomiphene group (68 couples) performed significantly better than the unstimulated group (64 couples) in terms of number of cycles with oocyte harvest (90/111 or 81% versus 65/114 or 57%; chi(2) = 9.21, P < 0.002), embryo transfers per started cycle (59/111 or 53% versus 29/114 or 25%; chi(2) = 18.14, P < 0.0001), live intrauterine pregnancy rate per started cycle (20/111 or 18% versus 4/114 or 4%; chi(2) = 12.42, P < 0.0001), live intrauterine pregnancy rate per embryo transfer (20/59 or 34% versus 4/29 or 14%; chi(2) = 3.96, P = 0.047), but not in terms of implantation rate (22/85 or 26% versus 4/29 or 14%; chi(2) = 1.65). Only two twin pregnancies occurred. Modest side-effects were recorded following clomiphene. Accordingly, a simple clomiphene citrate protocol, but not IVF in unstimulated cycles, seems compatible with the concept of 'friendly IVF', yielding a fair pregnancy rate both per cycle started and per embryo transfer in selected patients. The results do not substantiate any important negative anti-oestrogenic effects of clomiphene. 相似文献
10.
Fluid accumulation within the uterine cavity reduces pregnancy rates in women undergoing IVF 总被引:13,自引:0,他引:13
BACKGROUND: The occurrence of fluid accumulation within the uterine cavity was examined in women undergoing IVF to investigate its correlation with tubal disease and impact on the pregnancy outcome. METHODS: A registry of ultrasound procedures spanning 5 years was retrospectively studied. RESULTS: Thirty five out of 746 (4.7%) IVF cycles were identified as having uterine fluid accumulation, and 15 (2.0%) persisted until the day of embryo transfer. Two of the 20 cycles of women with transient fluid accumulation were pregnant, and none of those with fluid retention on the day of embryo transfer conceived. The pregnancy rate was only 5.7% (2/35) in women with uterine fluid accumulation detected during IVF cycles. In contrast, the pregnancy rate was 27.1% (193/711) among women in whose cycles no fluid accumulation was detected (P = 0.0048). Uterine fluid accumulation during IVF cycles was found in 8% (18/225) of women documented with tubal factor compared with 3.3% (17/521) with non-tubal factor (P = 0.005). CONCLUSIONS: Fluid accumulation within the uterine cavity during the IVF transfer treatment could be observed in patients with both tubal and non-tubal factors; however, it mainly occurred in women with tubal infertility. Although it is not a common complication of IVF cycles, excessive uterine fluid is detrimental to embryo implantation. 相似文献
11.
M S Mills H A Eddowes D J Cahill U M Fahy M I Abuzeid A McDermott M G Hull 《Human reproduction (Oxford, England)》1992,7(4):490-494
The relative effectiveness of in-vitro fertilization (IVF), gamete intra-Fallopian transfer (GIFT) and intrauterine insemination (IUI) combined with superovulation in the treatment of infertility were compared in 151 couples undergoing a single cycle of treatment. Treatment was selected as appropriate (IVF for tubal disease, GIFT or IUI/superovulation for nontubal infertility) but possible bias due to non-randomization was overcome by all couples having had favourable fertilization in a previous cycle of IVF. Furthermore, in a preliminary study of initial IVF treatment in 265 couples from whom the study patients were drawn, implantation and pregnancy rates in the diagnostic groups were similar. In the definitive study comparing IVF, GIFT and IUI/superovulation, the pregnancy rate observed with GIFT was highest (40%) but this was not significantly higher than with IVF (28%) or IUI/superovulation (20%). However, the implantation rate per egg transferred by GIFT (21%) was significantly higher than the implantation rate per embryo transferred by IVF (11%). Although the pregnancy rates with GIFT were not statistically greater than with IVF, a significant advantage is likely to be observed in larger groups in view of the better implantation rate. The lower pregnancy rates with IUI superovulation are to be expected because of limited ovarian stimulation, they are nevertheless of comparative interest. 相似文献
12.
Hull MG; Williams JA; Ray B; McLaughlin EA; Akande VA; Ford WC 《Human reproduction (Oxford, England)》1998,13(7):1825-1830
This study aims to determine the relative contribution of oocyte and/or
sperm dysfunction to the reduction of fertilization rates in vitro in cases
of minor endometriosis and prolonged unexplained infertility. The results
of in-vitro fertilization (IVF) treatment with ovarian stimulation have
been compared between couples with the above conditions and women with
tubal infertility (as control for oocyte function) and the use of donor
spermatozoa (as control for sperm function). Fertilization and cleavage
rates using husband's spermatozoa were significantly reduced in
endometriosis couples (56%, n = 194, P < 0.001) and further
significantly reduced in couples with unexplained infertility (52%, n =
327, P < 0.001) compared with tubal infertility (60%, n = 509). Using
donor spermatozoa the rates were the same as using husband's spermatozoa in
tubal infertility (61%, n = 27) or endometriosis (55%, n = 21) but
significantly though only partly improved with unexplained infertility
(57%, n = 60, P < 0.02). In unexplained infertility, a significantly
increased proportion of couples experienced complete failure of
fertilization and cleavage in a cycle (5-6% versus 2-3%). However, complete
failure was not usually repetitive, and the affected couples did not
account for the overall reduction in fertilization and cleavage rates,
which remained significantly lower in the rest of the unexplained and
endometriosis groups. Implantation and pregnancy rates appeared similar in
all groups. The benefit of IVF treatment in cases of minor endometriosis
and prolonged unexplained infertility is due to superabundance of oocytes
obtained by stimulation. The reduction in natural fertility associated with
endometriosis appears to be at least partly due to a reduced fertilizing
ability of the oocyte. In unexplained infertility, there is distinct
impairment due to otherwise unsuspected sperm dysfunction but probably also
oocyte dysfunction.
相似文献
13.
Development of embryos from natural cycle in-vitro fertilization: impact of medium type and female infertility factors 总被引:1,自引:1,他引:0
Monks N.J.; Turner K.; Hooper M.A.K.; Kumar A.; Verma S.; Lenton E.A. 《Human reproduction (Oxford, England)》1993,8(2):266-271
Single embryos derived from natural cycle in-vitro fertilization(IVF) were graded during the pre-transfer culture period usingmorphological criteria. Most embryos developed well in culturewith 96% showing continuing division and 68% showing good morphologicalappearance, although embryo quality tended to decline with anincreased incidence of fragmentation and uneven cleavage asdivision proceeded. Both the pregnancy rate and the distributionof embryo grades were similar among four different culture mediaused, suggesting that choice of medium had little impact onoutcome. In contrast, there were marked differences in pregnancyrate according to the type of infertility, which was not reflectedin a decrease in embryo quality. However, although embryos frompatients with tubal infertility implanted and formed viablepregnancies irrespective of morphological appearance, only goodquality embryos from patients with non-tubal (or unexplained)infertility were able to implant. Thus the appearance of theembryo derived from natural cycle IVF in women with unexplainedinfertility may be of clinical relevance. 相似文献
14.
Two different regimens of luteal support in gonadotrophin hormone-releasinghormone (GnRH) analoguefhuman menopausal gonadotrophin (GnRHa/HMG)-inducedin-vitro fertilization cycles (IVF) were compared in a randomizedclinical trial. After embryo transfer, either vaginal progesteronealone was administered (n=89, P group), or a combination ofvaginal progesterone and human chorionic gonadotrophin (n=87,P/HCG group). The primary aim of this study was to assess theeffect of the different regimens of luteal support on the pregnancyrate. The secondary aim was to compare oestradiol and progesteroneconcentrations in the luteal phase between the two groups, andassess their effect on the pregnancy rate. A clinical pregnancyrate of 15% was found in the P/HCG group in comparison with26% in the P group (odds ratio 0.49; 99% confidence interval:0.181.3). The luteal serum oestradiol and progesteronevalues in the P/HCG group were significantly higher when comparedwith the P group on the 6th, 9th and 12th day after oocyte retrieval(Wilcoxon P<0.001). In accordance with the high oestradiolconcentrations, more cases of ovarian hyperstimulation syndrome(OHSS) were found in the P/HCG group. Oestradiol values on the9th day after oocyte retrieval, presumably the day of implantation,appeared to be higher in women who did not become clinicallypregnant. We conclude that vaginal progesterone alone providessufficient luteal support in GnRHa/HMG induced IVF cycles. Thecombination of vaginal progesterone and HCG as luteal supportleads to significant high luteal oestradiol and progesteroneconcentrations. But a high concentration of oestradiol seemsto have a deleterious effect on the implantation process, resultingin a low pregnancy rate. 相似文献
15.
Fukuda Misao; Fukuda Kiyomi; Andersen Claus Yding; Byskov Anne Grete 《Human reproduction (Oxford, England)》1996,11(9):1958-1962
Ovulation was studied using vaginosonography in a total of 410natural cycles of 123 women undergoing infertility treatment[267 intrauterine insemination (IUI) cycles of 103 women and143 in-vitro fertilization (IVF) cycles of 50 women]. None ofthe women received ovarian stimulation. Each follicle was measureddaily from 14 mm in diameter until formation of corpus luteumor oocyte retrieval. Contralateral ovulation as compared withthe preceding cycle occurred in 57% of the 410 cycles. Contralateralovulations occurred in 72% of cycles with a follicular phase<13 days. In cycles with a follicular phase of >14 days,ovulations occurred at random. The length of follicular phasein contralateral ovulation cycles (15.2 ± 3.2 days) wassignificantly (P < 0.05) shorter than that of ipsilateralovulation cycles (15.8 ± 2.8). During the 57% contralateralovulations in 143 IVF cycles, the rates of oocyte retrieval(89%), fertilization (69%), cleavage (90%) and embryo transfer(56%) were significantly higher than those of ipsilateral ovulations(69, 51, 64 and 23% respectively). The pregnancy rate of contralateralovulations (9%) was also higher, though not significantly, thanthat of ipsilateral ovulations (3%), although the pregnancyrates per transfer were similar (16 and 14% respectively). Thetotal pregnancy rate of both IUI and IVF was higher in contralateralthan in ipsilateral ovulation cycles (8.1 and 4.0% respectively).The dominant follicles in contralateral ovulation cycles showedsignificantly higher oestradiol/androstenedlone ratio (P <0.025) and oestradlol/testosterone + androstenedione ratio (P< 0.025), and lower androstenedione (P < 0.05) than thoseof ipsilateral ovulation cycles. There was no significant differencein oestradiol, progesterone and testosterone. These resultsindicate that the dominant follicles in contralateral ovulationcycles are healthier than those of ipsilateral ones. Local intra-ovarianfactors, e.g. from the corpus luteum, may negatively affectthe health of the dominant follicle and the enclosed oocyte.Therefore contralateral selection of the dominant follicle inthe succeeding cycle may favour pre-embryo development. Thechance of conceiving during a natural cycle may be affectedby the site of ovulation in the preceding cycle. 相似文献
16.
Edelstam G Sjösten A Bjuresten K Ek I Wånggren K Spira J 《Human reproduction (Oxford, England)》2008,23(4):852-856
BACKGROUND: Artificial insemination (intrauterine insemination by husbandor artificial insemination by husband) is often tried as firsttreatment for couples with unexplained infertility. Pertubationhas previously proved to increase the chance of achieving pregnancyfor these couples. The effect of pertubation on fertility canbe mechanical as well as anti-inflammatory by using a substancethat inhibits phagocytosis of the spermatozoa. The objectiveof the study was to investigate the effect on pregnancy rateof pre-ovulatory pertubation with low-dose lignocaine duringclomiphene citrate and insemination cycles for couples withunexplained infertility. METHODS: In a prospective, open study, the patients were randomized,the day before ovulation, during a clomiphene citrate stimulatedcycle to either pertubation with low-dose local anaestheticor no pertubation before insemination. RESULTS: A total of 130 cycles were studied, 67 of which were randomizedto pre-ovulatory pertubation and 63 to no pertubation treatment.There were 14.9% (n = 10) clinical pregnancies in the pertubatedgroup compared with 3.2% (n = 2) in the group without pre-ovulatorypertubation (P < 0.05). CONCLUSIONS: The pertubation treatment significantly enhanced the clinicalpregnancy rate and was well tolerated. No complications werenoted. The combined treatment of clomiphene citrate, pertubationand insemination can be used as a cost-effective, first-linetreatment for couples with unexplained infertility. 相似文献
17.
A I Mackenna F Zegers-Hochschild E O Fernandez C V Fabres C A Huidobro J A Prado L S Roblero E L Altieri A R Guadarrama T H Lopez 《Human reproduction (Oxford, England)》1992,7(2):223-226
A group of 24 couples with unexplained infertility was scheduled for in-vitro fertilization and tubal embryo transfer between May 1989 and September 1990. In the same period, in-vitro fertilization and intrauterine transfer of embryos was planned in a control group of 44 women with tubal infertility. The mean age and duration of infertility were similar in both groups and the same scheme of ovarian stimulation was used. No statistically significant difference was obtained comparing oestradiol levels and numbers of mature oocytes retrieved between the group of patients with unexplained infertility and those with tubal infertility. The fertilization rate of the oocytes obtained from women with unexplained infertility (60.4%) was significantly lower (P less than 0.001) than that of the oocytes obtained from patients with tubal infertility (87.3%). There was no statistically significant difference in the cleavage rates between patients with unexplained infertility and those with tubal infertility. It is concluded that lack of fertilization is an unexplored cause of infertility in couples with unexplained infertility. 相似文献
18.
Pregnancy outcome after IVF and ICSI in unexplained, endometriosis-associated and tubal factor infertility 总被引:3,自引:0,他引:3
Omland AK Abyholm T Fedorcsák P Ertzeid G Oldereid NB Bjercke S Tanbo T 《Human reproduction (Oxford, England)》2005,20(3):722-727
BACKGROUND: This study was undertaken in order to compare pregnancy outcome after IVF and ICSI in unexplained and endometriosis-associated infertility using tubal factor infertility as controls. METHODS: This was a retrospective cohort study of early IVF/ICSI pregnancies verified by serum hCG measurement, comparing the subsequent outcome in unexplained (n = 274) and minimal endometriosis-associated (n = 212) with tubal factor (n = 540) infertility as controls. From January 1990 to December 2002, 1026 conception cycles after treatment with IVF or ICSI complied with the inclusion criteria. RESULTS: Live birth rate, twin birth rate after transfer of two embryos and abortion rate prior to 6 weeks of gestation were superior for the unexplained (78.8, 23.5 and 11.7%) compared to endometriosis-associated (66.0, 15.0 and 19.3%) and tubal factor (66.7, 18.1 and 18.0%) infertility groups (P < 0.05). Compared to the endometriosis-associated, the unexplained infertility group attained a higher pregnancy rate after the first treatment cycle (P < 0.05). CONCLUSIONS: The overall better outcome for the unexplained infertility group with respect to live birth rate, twin birth rate and early abortion rate compared to the minimal peritoneal endometriosis-associated and tubal factor infertility groups might be a guide to select diagnostic groups for single embryo transfer and be useful in patient counselling. 相似文献
19.
BACKGROUND: As more women choose to delay childbearing, increasing numbersof them face age-related fertility problems. We aimed to explorethe association between age and diagnosed causes of female infertility. METHODS: Anonymized data (age of male and female partner, year of firstvisit, diagnosis, duration and type of infertility) were obtainedon all couples attending Aberdeen Fertility Centre from 1993–2006.The prevalence of different causes of infertility was determinedfor women <35 and 35 years of age at the time of their firstclinic visit. Binary logistic regression and multinomial regressionwere used to determine the association between age and diagnosticcategories of infertility. RESULTS: Of a total of 7172 women, 26.9% were over the age of 35 yearsand 51.4% of the total had primary infertility. The mean femaleage was 31.2 (5.2 SD) years. There was an association betweenfemale age and the cause of female infertility (likelihood ratio,P < 0.001). More women over 35 had unexplained infertility(26.6 versus 21.0%, P < 0.001). Compared with women under30 years, the adjusted odds ratio (95% confidence intervals,CI) of the following diagnoses in women over 35 were: unexplainedinfertility = 1.8 (1.4–2.2), ovulatory dysfunction = 0.3(0.3–0.4) and tubal factor = 2.2 (1.7–2.7). CONCLUSIONS: The causes of infertility in older women are different fromthose in younger women. Women over 35 years of age are nearlytwice as likely to present with unexplained infertility. 相似文献
20.
Sauer M.V.; Paulson R.J.; Francis M.M.; Macaso T.M.; Lobo R.A. 《Human reproduction (Oxford, England)》1995,10(6):1419-1422
The experience of transferring embryos produced through in-vitrofertilization (IVF) utilizing donated oocytes and spermatozoais described. Recipients (n = 28; aged 3859 years) receivedoral micronized oestradiol and i.m. progesterone and were synchronizedto donors undergoing ovarian stimulation. Reasons for selectingtherapy included advanced reproductive age (>42 years; n= 21) or hyper-gonadotrophic hypogonadism (n = 7), combinedwith severe male factor infertility in 23 couples. Five womenwere single and without partners. Oocytes were fertilized bycryopreserved spermatozoa designated for use by the recipient.Up to five embryos were transferred trans-cervically. Supernumeraryembryos were cryopreserved. A total of 36 aspirations produced15.6 ± 7.3 oocytes per retrieval. In 10/36 cycles (27.8%),embryos were available for cryopreservation. Using fresh embryos,the overall pregnancy rate was 38.9% (14/36), clinical pregnancyrate 33.3% (12/36), and ongoing/delivered pregnancy rate 30.6%(11/36). Three ongoing pregnancies were later established bytransferring cryopreserved embryos. Adjusting for these events,the per aspiration overall pregnancy rate per retrieval was47.2%, clinical pregnancy rate 41.7%, and ongoing/deliveredpregnancy rate 38.9%. Implantation rates per individual embryotransferred were 16.6% following fresh embryo transfer. A viablepregnancy was achieved by 14 of 28 women (50% cumulative pregnancyrate). We conclude that using donor oocytes and donor spermatozoais efficacious and allows couples of whom both members sufferfrom severe gamete abnormalities and single functionally agonadalwomen an effective means of achieving pregnancy. 相似文献